Search - tctmd.com

Displaying 21 - 40 of 818

Sort: Relevancy | Date

Presentation TCT 2025

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

Presenter: Ruben W. de Winter

October 28, 2025

Presentation TCT 2025

TTVI: Updates from Clinical Trials and Registries

Presenter: Jörg Hausleiter

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

Presenter: Alexandra Popma

October 27, 2025

Presentation TCT 2025

The Challenges of Recurrent Event Models and Multiple Endpoints

Presenter: Daniele Giacoppo

October 27, 2025

Presentation TCT 2025

Estimands: Clarifying What We’re Measuring in Clinical Trials

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Current Trials to Extend LAAC Clinical Indications

Presenter: Shephal K. Doshi

October 27, 2025

Presentation TCT 2025

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Presenter: John A. Spertus

October 27, 2025

Presentation TCT 2025

Placebo-Controlled Interventional Trials: A Sham No More

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Presenter: Hugh Lurcott

October 27, 2025

Presentation TCT 2025

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Presenter: Evald H. Christiansen

October 27, 2025

Presentation TCT 2025

Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial

Presenter: Chao Gao

October 27, 2025

Presentation TCT 2025

TCT 447: Invisible Hearts: The Underrepresentation of Women in Cardiovascular Clinical Trials

Presenter: Pablo Juan Salvadores

October 27, 2025

Presentation TCT 2025

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Presenter: Lei Song

October 27, 2025

Presentation TCT 2025

Modifying the Win Ratio for Noninferiority Trials: A Bridge Too Far?

Presenter: Björn Redfors

October 27, 2025

Advertisement

Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery (PROCTOR): A Multicenter, Open-label, Randomized Trial

TTVI: Updates from Clinical Trials and Registries

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

The Challenges of Recurrent Event Models and Multiple Endpoints

Estimands: Clarifying What We’re Measuring in Clinical Trials

Pragmatic, Adapted, and Augmented Trials: Ready for Regulatory Approval

Current Trials to Extend LAAC Clinical Indications

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Placebo-Controlled Interventional Trials: A Sham No More

TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial

TCT 447: Invisible Hearts: The Underrepresentation of Women in Cardiovascular Clinical Trials

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Modifying the Win Ratio for Noninferiority Trials: A Bridge Too Far?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content